"Sending the Right Signals to the Immune System"

Martin Welschof of Opsona Therapeutics joined us for World Orphan Drug Congress USA 2015 to present about ‘ Sending the Right Signals to the Immune System’.

Download the presentation now to understand more about:

The value of targeting TLRs
Opsona’s lead compound OPN-305
Efficacy: convincing data in pre-clinical studies
OPN-305 Overall Clinical Development Strategy

…and much more!

Get your copy here!

To find out more about Opsona Therapeutics and OPN-305 , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.

[[ Whitepaper ]] Connecting With Rare Disease Patient Communities: Patient Advocates

[[Whitepaper ]] Disruptive Innovation in Rare Disease Markets

Choosing the Right Channel Strategy for Specialty Product Success

[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

[[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches

What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)

“Sending the Right Signals to the Immune System”

Categories